These indicated that lncRNA HOTAIR and its genetic variations may be a potential target for risk evaluation, early detection and therapeutic target of PC; and larger prospective and experimental studies were warranted to further validation. This evidence concerns the gene HOTAIR and pachyonychia congenita.